Ir para o conteúdo

Josh Lang

@joshlangmd.bsky.social did:plc:ogakdmlnkdx4iseoo2k7fcis

Professor and Associate Director of Translational Research, GU Medical Oncologist at the University of Wisconsin Carbone Cancer Center. https://langlab.labs.wisc.edu/ #prostatecancer #cancerbiology #biomarkers

No Bluesky desde

Seguidores
353
Seguindo
182
Posts
54
Dias nos rankings
0

Resumo

Josh Lang (@joshlangmd.bsky.social) é um usuário do Bluesky desde 18 novembro 2024. Tem 353 seguidores, segue 182 contas e publicou 54 posts.

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

  • Amy Weeks@amyweeks.bsky.social

    Excited that our paper on enzymatic bromination of peptides is now online at ACS Chemical Biology! Led by Haley Bridge, we showed that the flavin-dependent halogenase RebH and its variants can be used for late-stage chemoenzymatic diversification of bioactive peptides: pubs.acs.org/doi/10.1021/...

    Ver post
  • EACR - European Association for Cancer Research@helloeacr.bsky.social

    Anyone can register for Thursday's FREE webinar on 'Unmasking Cancer Complexity: Gaining Multi-Dimensional Clarity through Multiomic Innovation'. 15:00 CET. Register: us02web.zoom.us/webinar/regi...

    Ver post
  • Roychoudhuri Lab@roychoudhurilab.bsky.social

    Thrilled to share our latest work: Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy - now online in Nature Immunology. Led by Alberto Conti, Alex Evans and Teresa von Linde in the lab. www.nature.com/articles/s41...

    Ver post
  • Adam Sharp@asharpmedonc.bsky.social

    Day 15 of 31 (another one down) - runthemonthme.prostatecanceruk.org/fundraising/...

    Ver post
  • Adam Sharp@asharpmedonc.bsky.social

    Worried about the snow on Boston!

    Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.